Herbal Monograph
Black Seed
Nigella sativa L.
Ranunculaceae (Buttercup family)
Prophetic medicine's universal remedy for metabolic health, immunity, and respiratory support
Overview
Plant Description
Nigella sativa is a slender, erect annual herbaceous plant growing 20-60 cm (8-24 inches) tall, with a branching, ridged stem bearing finely dissected, pinnate leaves with linear, thread-like segments that give the foliage a delicate, feathery appearance. The flowers are solitary, terminal, and actinomorphic, with 5-10 delicate petals ranging from pale blue to white, often with subtle green veining. The petals surround a prominent central cluster of stamens and 5-10 fused carpels. The fruit is a large, inflated capsule (follicle) composed of 3-7 united follicles, each containing numerous small seeds. The seeds are the medicinally important part: small (2-3 mm long), angular-ovoid to trigonous in shape, with a rough, granular black surface (testa) and an oily white interior. The seeds are aromatic when crushed, releasing a complex, warm, peppery fragrance. The taste of the seeds is distinctly pungent and slightly bitter with aromatic, warm undertones reminiscent of a combination of oregano, pepper, and onion. The plant is frost-sensitive, completing its entire life cycle within one growing season. The species epithet 'sativa' means 'cultivated,' reflecting its long history of domestication.
Habitat
Nigella sativa thrives in warm, dry climates with well-drained, sandy to loamy soils in full sun. It is drought-tolerant once established and prefers alkaline to neutral soil pH (6.5-7.5). The plant grows naturally in disturbed ground, field margins, and semi-arid scrubland. It does not tolerate waterlogged soils or heavy shade. In its native range, it grows at elevations from sea level to approximately 1500 meters in Mediterranean and semi-arid zones.
Distribution
Native to the eastern Mediterranean region, southwestern Asia, and the Middle East, particularly the area spanning from Turkey and Syria through Iraq, Iran, and into Pakistan and northern India. Now cultivated extensively throughout the Middle East, North Africa (especially Egypt and Ethiopia), the Indian subcontinent (India, Bangladesh, Pakistan), Central Asia, and parts of Southeast Asia. Egypt, India, Syria, Turkey, and Saudi Arabia are major contemporary producers. The plant has been introduced and cultivated on a smaller scale in southern Europe, East Africa, and parts of the Americas. Its distribution closely follows the historic trade routes of the Islamic world, reflecting the central role of the seed in Prophetic medicine.
Parts Used
Seed (Semen Nigellae)
Preferred: Whole seeds (traditional); ground seed powder in capsules; cold-pressed seed oil
The dried ripe seed is the primary medicinal part, used whole, ground, or as the source material for oil extraction. Seeds contain the full complement of bioactive constituents including thymoquinone, fixed oils, essential oils, alkaloids, saponins, and proteins. Whole seeds are used in traditional Prophetic medicine (chewed, mixed with honey, or added to food). Ground seed powder is encapsulated or mixed into preparations. The characteristic pungent, aromatic taste and warming sensation of the seeds is attributable to the volatile oil constituents, particularly thymoquinone and p-cymene.
Fixed oil (Oleum Nigellae sativae, Black Seed Oil)
Preferred: Cold-pressed seed oil in capsules or liquid form; supercritical CO2 extract for higher thymoquinone standardization
Cold-pressed oil extracted from the seeds, containing a concentrated source of thymoquinone (typically 0.5-3.0% w/w in cold-pressed oil, though this varies with seed origin, extraction method, and storage conditions) along with the full fatty acid profile (primarily linoleic acid 50-60%, oleic acid 20-25%, palmitic acid 12-15%). The oil is the most widely studied and commercially available preparation in modern practice. Supercritical CO2 extraction yields higher thymoquinone concentrations than conventional cold-pressing. The oil is dark amber to greenish-black in color with a strong, pungent, characteristic aroma.
Essential oil (volatile oil fraction)
Preferred: Steam-distilled essential oil; used diluted for topical application or in very small oral doses (1-2 drops)
Steam-distilled essential oil comprising the volatile constituents of the seed, primarily thymoquinone (27-57%), p-cymene (7-15%), alpha-pinene (1-8%), carvacrol, thymol, and longifolene. Used in much smaller doses than the fixed oil. The essential oil is significantly more concentrated in thymoquinone and other terpenes than the cold-pressed fixed oil. Applied topically (diluted) or taken internally in very small doses. Should be used with appropriate dilution and caution due to concentrated volatile constituents.
Key Constituents
Quinones and terpenes (volatile oil constituents)
The quinone and terpene constituents, led by thymoquinone, are the primary drivers of the pharmacological activity of Nigella sativa. Thymoquinone alone accounts for the majority of the documented anti-inflammatory, antioxidant, immunomodulatory, hepatoprotective, hypoglycemic, and antimicrobial effects. The presence of structurally related compounds (thymohydroquinone, thymol, carvacrol) creates a potential synergistic ensemble. Thymoquinone content serves as the primary quality marker for black seed products; standardization to thymoquinone content is the industry standard for therapeutic-grade preparations. These constituents are lipophilic and best delivered in oil-based preparations (seed oil, soft-gel capsules) rather than aqueous preparations.
Fixed oils (fatty acids and lipids)
The fixed oil constitutes 30-40% of the seed by weight and serves both as the lipid matrix for thymoquinone delivery and as a source of essential fatty acids in its own right. The favorable ratio of unsaturated to saturated fatty acids (approximately 4:1) contributes to the hypolipidemic and cardiovascular protective effects observed in clinical studies. The fixed oil also provides the vehicle for oral administration of the lipophilic bioactive constituents, enhancing their absorption. Cold-pressing preserves the thymoquinone content better than solvent extraction or high-heat processing.
Alkaloids
The alkaloid fraction of N. sativa is pharmacologically interesting but present in small quantities relative to the dominant quinone and fixed oil constituents. Nigellidine and nigellicine may contribute to anti-inflammatory and analgesic effects. The alkaloids are likely minor contributors to the overall therapeutic profile when the whole seed or seed oil is used, but represent potential targets for pharmaceutical development.
Saponins
The saponin fraction contributes to the expectorant, mucolytic, and anti-tumor activities of N. sativa. Alpha-hederin in particular has received attention for its cytotoxic and immunostimulant properties. Saponins also enhance the bioavailability of other constituents through their detergent-like membrane effects.
Vitamins and minerals
The vitamin E content provides endogenous antioxidant protection for the oil and contributes additional antioxidant activity when consumed. Phytosterols contribute to the lipid-lowering effects observed in clinical studies. The mineral content supports the traditional use of N. sativa as a general nutritive tonic but is not the primary basis for therapeutic recommendations.
Proteins and amino acids
The protein content of whole seeds contributes to their nutritive value in traditional culinary-medicinal use. Some isolated seed proteins have demonstrated immunomodulatory and antifungal activity in vitro, but the therapeutic significance of the protein fraction is considered minor relative to the thymoquinone and fixed oil constituents.
Herbal Actions
Reduces inflammation
One of the best-documented pharmacological actions of Nigella sativa. Thymoquinone potently inhibits the NF-kB signaling pathway, downregulating expression of COX-2, 5-lipoxygenase, iNOS, TNF-alpha, IL-1beta, IL-6, and other pro-inflammatory mediators. Multiple meta-analyses and systematic reviews confirm clinically measurable anti-inflammatory effects. Daryabeygi-Khotbehsara et al. (2017) meta-analysis of RCTs found significant reductions in serum inflammatory markers (CRP, TNF-alpha) with N. sativa supplementation. The anti-inflammatory activity underpins many of the secondary therapeutic effects including joint pain relief, respiratory improvements, and metabolic benefits.
[1, 2, 3, 6]Modulates and balances immune function
Nigella sativa demonstrates bidirectional immunomodulation: enhancing suppressed immune function while modulating overactive immune responses. Thymoquinone and whole seed extracts increase NK cell cytotoxicity, enhance macrophage phagocytic activity, stimulate T-lymphocyte proliferation, and modulate Th1/Th2 cytokine balance. In allergic and autoimmune conditions, N. sativa may help rebalance the immune response by shifting from Th2-dominant to Th1-dominant patterns. Salem (2005) comprehensive review documented immunomodulatory effects across multiple experimental systems. Clinical studies have shown improved immune parameters in healthy subjects and in patients with various immune-related conditions.
[1, 2, 4]Prevents or slows oxidative damage to cells
Thymoquinone is a potent antioxidant acting through multiple mechanisms: direct scavenging of superoxide anion, hydroxyl radicals, and singlet oxygen; enhancement of endogenous antioxidant enzyme activity (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase); replenishment of intracellular glutathione (GSH) levels; and inhibition of lipid peroxidation. The antioxidant activity is central to the hepatoprotective, nephroprotective, neuroprotective, and cardioprotective effects attributed to N. sativa. The fixed oil's tocopherol content provides additional antioxidant support.
[1, 2, 3]Protects the liver from damage
Robust preclinical and emerging clinical evidence supports hepatoprotective activity. Thymoquinone protects hepatocytes against a wide range of toxicants in animal models including carbon tetrachloride, acetaminophen, ischemia-reperfusion injury, D-galactosamine, aflatoxins, and chemotherapy-induced liver damage. Mechanisms include: enhancement of hepatic glutathione and antioxidant enzyme systems, reduction of lipid peroxidation, suppression of NF-kB-mediated hepatic inflammation, and prevention of hepatic fibrosis. Clinical studies have shown reductions in liver enzymes (ALT, AST) in patients with non-alcoholic fatty liver disease (NAFLD) with N. sativa supplementation.
[1, 2, 3]Kills or inhibits the growth of microorganisms
Broad-spectrum antimicrobial activity demonstrated in vitro and in vivo. Thymoquinone, thymohydroquinone, thymol, and carvacrol contribute synergistically to activity against Gram-positive bacteria (Staphylococcus aureus, including MRSA), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa), fungi (Candida albicans, dermatophytes), and some parasites (Schistosoma, Leishmania). Clinical relevance at typical oral doses is less well-established than in vitro activity; topical application for skin infections has more direct applicability. The seeds have been traditionally used as a food preservative in some cultures, reflecting their antimicrobial properties.
[1, 2, 4]Promotes the discharge of mucus from the respiratory tract
Traditional use for respiratory conditions including cough, asthma, and bronchitis is supported by pharmacological evidence. Nigellone (dithymoquinone) and thymoquinone demonstrate bronchodilatory activity through calcium channel blockade and inhibition of histamine release from mast cells. Saponin content (alpha-hederin) contributes to mucolytic and expectorant effects. An RCT by Boskabady et al. (2007) demonstrated improvement in pulmonary function tests (FEV1, PEFR) in asthmatic patients treated with boiled N. sativa seed extract.
[1, 2, 8]Relieves intestinal gas and bloating
The volatile oil fraction provides carminative (gas-relieving) and digestive-soothing action consistent with the seed's traditional use as a digestive spice. The pungent aromatic constituents (thymoquinone, p-cymene, carvacrol) stimulate digestive secretions, relax intestinal smooth muscle spasm, and reduce gas formation. This action supports the traditional use of black seed in food preparation and as a post-meal digestive aid across Middle Eastern, South Asian, and North African cuisines.
[1, 16]Relieves pain
Analgesic activity demonstrated in multiple preclinical pain models including hot-plate, tail-flick, and formalin tests. Thymoquinone's analgesic mechanism involves inhibition of prostaglandin synthesis (COX-2 inhibition), suppression of substance P, and potential opioid receptor modulation. p-Cymene also demonstrates independent analgesic activity. Clinical evidence is preliminary but traditional use for headache, joint pain, and toothache is well-documented.
[1, 2]Lowers blood pressure
Modest blood pressure-lowering effects observed in clinical studies. A meta-analysis by Sahebkar et al. (2016) of RCTs found that N. sativa supplementation significantly reduced systolic blood pressure (mean reduction approximately 3.3 mmHg). Mechanisms include diuretic action, calcium channel blockade, and nitric oxide-mediated vasodilation. The effect is mild and dose-dependent, supporting use as a complementary rather than primary antihypertensive intervention.
[1, 7]Increases urine production and output
Mild diuretic activity demonstrated in animal models. N. sativa seed extract increases urine volume and sodium excretion, contributing to the blood pressure-lowering effects. Traditional Unani medicine classifies black seed as mildly diuretic. The diuretic effect is gentle and unlikely to cause significant electrolyte disturbance at typical therapeutic doses.
[1, 17]Promotes breast milk production
Traditional use as a galactagogue (breast milk promoter) is documented in Islamic and Unani medicine. Habbatus Sauda mixed with honey or fenugreek is a traditional postpartum preparation in many Middle Eastern and South Asian cultures. Limited modern clinical data specifically validating this use, but the tradition is longstanding and consistent across multiple cultural practices.
[1, 16]Therapeutic Indications
Immune System
Immune system support and enhancement
N. sativa demonstrates significant immunomodulatory effects in both preclinical and clinical studies. Thymoquinone and whole seed extracts enhance NK cell activity, stimulate T-lymphocyte proliferation, and improve macrophage function. Salem (2005) comprehensive review documented consistent immunopotentiating effects across multiple experimental systems. Clinical trials have shown increased CD4+ T-cell counts and improved CD4/CD8 ratios in healthy subjects and in HIV-positive patients as adjunctive therapy. Traditional Prophetic medicine recommendation as a general health tonic aligns with the immunomodulatory evidence.
[1, 2, 4]Allergic rhinitis and seasonal allergies
Multiple clinical trials support the use of N. sativa oil for allergic rhinitis. Nikakhlagh et al. (2011) RCT found significant improvement in nasal mucosal congestion, nasal itching, runny nose, sneezing attacks, and turbinate hypertrophy after 2 weeks of intranasal N. sativa oil application. The anti-allergic mechanism involves inhibition of histamine release from mast cells, Th1/Th2 rebalancing, and suppression of IgE production. Traditional use for allergic conditions is well-documented in Islamic and Unani medicine.
[1, 4, 9]Recurrent infections and immune deficiency
The traditional use of black seed as a general protective against illness and infection is extensive across Islamic, Ayurvedic, and Unani medical traditions. The broad-spectrum antimicrobial activity and immune-enhancing effects provide pharmacological rationale for this traditional indication. Clinical evidence specific to reducing infection frequency is limited to small studies and traditional documentation.
[4, 16]Respiratory System
Asthma (adjunctive therapy)
Clinical trials support bronchodilatory and anti-asthmatic effects. Boskabady et al. (2007) demonstrated significant improvement in pulmonary function tests (FEV1, peak expiratory flow rate) in asthmatic patients treated with boiled N. sativa extract compared to placebo. Nigellone inhibits histamine release and relaxes tracheal smooth muscle via calcium channel blockade. A systematic review by Koshak et al. (2017) confirmed beneficial effects on asthma symptoms and lung function across multiple studies. N. sativa is used as adjunctive therapy alongside conventional treatment, not as a replacement.
[1, 8, 10]Chronic cough and bronchitis
Extensive traditional use for cough and respiratory phlegm across Islamic, Unani, and Ayurvedic medicine. The expectorant (alpha-hederin saponins), bronchodilatory (thymoquinone, nigellone), and anti-inflammatory actions provide pharmacological rationale. The warm, dispersive energetics are well-suited for productive coughs with thick phlegm. Clinical evidence specific to chronic bronchitis is limited to traditional documentation and small observational studies.
[1, 8, 16]Allergic asthma and airway hyperreactivity
The combination of anti-allergic (histamine release inhibition, IgE reduction), anti-inflammatory (NF-kB suppression), and bronchodilatory effects makes N. sativa particularly suitable for allergic-type asthma. Preclinical studies demonstrate reduction in airway hyperresponsiveness, eosinophilic infiltration, and Th2 cytokine levels. Clinical trials are supportive but further large-scale studies are needed.
[8, 10]Endocrine System
Type 2 diabetes mellitus (adjunctive glycemic control)
Multiple RCTs and meta-analyses support the hypoglycemic and insulin-sensitizing effects of N. sativa. Bamosa et al. (2010) landmark RCT demonstrated significant dose-dependent reductions in fasting blood glucose and HbA1c in type 2 diabetic patients taking 2g/day of N. sativa seed for 12 weeks. Daryabeygi-Khotbehsara et al. (2017) meta-analysis confirmed significant reductions in fasting blood glucose and HbA1c across pooled RCTs. Mechanisms include: partial regeneration of pancreatic beta-cells (demonstrated in animal models), improvement of insulin sensitivity, enhancement of hepatic glucokinase activity, and inhibition of intestinal glucose absorption. Used as adjunctive therapy alongside conventional diabetes management.
[1, 5, 6]Metabolic syndrome and insulin resistance
N. sativa addresses multiple components of metabolic syndrome simultaneously: reducing blood glucose, improving lipid profiles, lowering blood pressure, and reducing inflammatory markers. The Daryabeygi-Khotbehsara et al. (2017) meta-analysis documented significant improvements across metabolic parameters. The multi-target activity profile makes N. sativa a particularly rational choice for the complex, interconnected metabolic disturbances of metabolic syndrome.
[5, 6, 7]Hashimoto's thyroiditis (adjunctive)
A randomized placebo-controlled trial by Farhangi et al. (2016) in patients with Hashimoto's thyroiditis found that N. sativa supplementation (2g/day for 8 weeks) significantly reduced body weight, BMI, serum TSH, anti-TPO antibodies, and serum VEGF while increasing serum T3 concentrations. These results suggest a potential modulatory effect on autoimmune thyroid function, though replication in larger trials is needed.
[1, 13]Cardiovascular System
Dyslipidemia (elevated cholesterol and triglycerides)
Multiple RCTs and meta-analyses confirm hypolipidemic effects. Sahebkar et al. (2016) meta-analysis found that N. sativa supplementation significantly reduced total cholesterol, LDL-C, and triglycerides while modestly increasing HDL-C. Mechanisms include: inhibition of HMG-CoA reductase (the statin target), enhanced LDL receptor expression, inhibition of intestinal cholesterol absorption (phytosterols), and suppression of hepatic lipogenesis. The lipid-lowering effects are clinically meaningful though more modest than pharmaceutical statins.
[1, 6, 7]Mild hypertension (adjunctive blood pressure management)
Sahebkar et al. (2016) meta-analysis of RCTs demonstrated significant reductions in both systolic and diastolic blood pressure with N. sativa supplementation. The effect is modest (approximately 3-5 mmHg systolic) but clinically relevant as part of a comprehensive lifestyle approach to blood pressure management. Mechanisms include calcium channel blockade, diuretic action, and nitric oxide-mediated vasodilation.
[1, 7]Atherosclerosis prevention and cardiovascular risk reduction
The combination of anti-inflammatory, antioxidant, hypolipidemic, antihypertensive, and antiplatelet activities suggests a multi-target cardioprotective profile. Preclinical studies demonstrate inhibition of atherosclerotic plaque formation and reduction of oxidized LDL. Long-term cardiovascular outcome data from clinical trials are not yet available, but the overall risk factor modification profile is favorable.
[1, 2, 7]Hepatobiliary System
Non-alcoholic fatty liver disease (NAFLD)
Emerging clinical evidence supports N. sativa supplementation in NAFLD. Randomized controlled trials have demonstrated reductions in hepatic steatosis (fatty infiltration), liver enzymes (ALT, AST), and inflammatory markers in NAFLD patients. Thymoquinone protects hepatocytes from oxidative stress, reduces hepatic lipid accumulation, and attenuates liver fibrosis in animal models. The simultaneous improvement in metabolic parameters (glucose, lipids, inflammation) provides additional benefit for the metabolic drivers of NAFLD.
[1, 3, 6]Hepatoprotection (drug- and toxin-induced liver injury)
Robust preclinical evidence demonstrates protection against a wide range of hepatotoxicants including acetaminophen, carbon tetrachloride, D-galactosamine, aflatoxins, cisplatin, methotrexate, and ischemia-reperfusion injury. Thymoquinone's hepatoprotective mechanism centers on enhancement of the glutathione antioxidant system, inhibition of lipid peroxidation, and suppression of NF-kB-mediated hepatic inflammation. Clinical studies confirm reductions in liver enzymes. Traditional use for liver protection is documented across multiple medical traditions.
[1, 2, 3]Biliary support and digestive bitters
The bitter and pungent taste of black seed stimulates bile flow and digestive secretions through the bitter reflex pathway. Traditional Unani medicine specifically classifies N. sativa as cholagogue (bile-promoting). The carminative volatile oils complement the bitter action for comprehensive digestive support.
[16, 17]Digestive System
Dyspepsia and functional gastrointestinal complaints
Long-standing traditional use as a digestive spice and carminative across Middle Eastern, South Asian, and North African cuisines and medical traditions. The aromatic volatile oils stimulate digestive secretions, relax intestinal smooth muscle spasm, and reduce gas formation. Traditionally used for bloating, flatulence, poor appetite, and generalized abdominal discomfort. The warm, pungent energetics are well-suited for cold, sluggish digestive patterns.
[1, 16, 17]Helicobacter pylori infection (adjunctive)
Salem et al. (2010) demonstrated anti-Helicobacter pylori activity comparable to triple therapy in a clinical trial using N. sativa seeds (2g/day) combined with omeprazole. In vitro studies confirm bactericidal activity against H. pylori clinical isolates. The gastroprotective properties of thymoquinone (enhancing gastric mucosal defense, reducing acid secretion) complement the antimicrobial action. Further large-scale trials are needed.
[1, 14]Intestinal parasites
Traditional antiparasitic use is documented in Islamic, Unani, and African folk medicine. In vitro and in vivo studies demonstrate activity against Schistosoma mansoni, Plasmodium species, Leishmania, and various intestinal helminths. The pungent volatile oils and thymoquinone contribute to the antiparasitic effect. Clinical evidence is limited to small studies and case reports.
[2, 16]Musculoskeletal System
Rheumatoid arthritis (adjunctive anti-inflammatory support)
An RCT by Hadi et al. (2016) in female patients with rheumatoid arthritis found that N. sativa oil supplementation (500 mg twice daily for 8 weeks) significantly reduced Disease Activity Score (DAS-28), number of swollen joints, and morning stiffness duration compared to placebo. Serum inflammatory markers (TNF-alpha, IL-10) were also improved. The potent NF-kB inhibition by thymoquinone provides a strong pharmacological rationale for anti-arthritic effects. Additional controlled trials are needed.
[1, 2, 11]Joint pain and inflammatory arthritis (general)
Traditional use for joint pain, swelling, and stiffness is documented in Unani and Islamic medicine. Topical application of black seed oil to affected joints is a traditional practice. The anti-inflammatory (COX-2 and LOX inhibition) and analgesic actions support this indication. Ibn Sina (Avicenna) described black seed for joint conditions in the Canon of Medicine.
[1, 17]Skin / Integumentary
Eczema and atopic dermatitis
The combination of anti-inflammatory, anti-allergic, antimicrobial, and moisturizing (fixed oil) properties makes N. sativa oil a rational topical treatment for eczema and atopic dermatitis. Small clinical studies have reported improvement in hand eczema severity with topical application. The immunomodulatory effects (Th1/Th2 rebalancing) may address the underlying allergic/immune dysregulation of atopic dermatitis. Internal use complements topical application.
[1, 2]Wound healing and skin infections
Traditional topical use for wound healing, burns, and skin infections is well-documented. Thymoquinone promotes wound healing through anti-inflammatory, antimicrobial, and antioxidant mechanisms. In vivo studies demonstrate accelerated wound closure and enhanced collagen synthesis. The antimicrobial activity against Staphylococcus aureus (including MRSA) is particularly relevant for infected wounds.
[2, 16]Acne vulgaris
A clinical study found that topical application of N. sativa oil lotion (10% and 20%) significantly reduced acne lesion count after 2 months of treatment. The antimicrobial activity against Propionibacterium acnes, anti-inflammatory effects, and sebum-modulating properties provide pharmacological rationale. Traditional use for skin blemishes is documented in Unani medicine.
[1, 2]Reproductive System
Male infertility and sperm quality improvement
Clinical trials have demonstrated improved sperm count, motility, morphology, and semen volume with N. sativa supplementation in infertile men. An RCT by Kolahdooz et al. (2014) found significant improvements in sperm parameters with 2.5 mL/day of N. sativa oil for 2 months. The antioxidant properties of thymoquinone protect sperm from oxidative stress-induced damage. Traditional use as an aphrodisiac and fertility aid is documented in Islamic and Unani medicine.
[1, 12]Dysmenorrhea (painful menstruation)
Traditional Unani medicine documents use of Habbatus Sauda for menstrual pain and irregularity. The antispasmodic action on smooth muscle (calcium channel blockade) and analgesic properties (COX-2 inhibition) provide pharmacological rationale for menstrual pain relief. Clinical data specific to dysmenorrhea are limited.
[1, 17]Nervous System
Epilepsy (adjunctive anticonvulsant support)
Traditional use as an anticonvulsant is documented in Islamic medicine. Preclinical studies demonstrate potent anticonvulsant activity of thymoquinone in multiple seizure models (pentylenetetrazol, maximal electroshock, pilocarpine). An RCT in pediatric epilepsy patients found that N. sativa extract as adjunctive therapy significantly reduced seizure frequency compared to placebo. The anticonvulsant mechanism may involve GABAergic modulation and opioid receptor activation. Use as adjunctive therapy only, under medical supervision.
[1, 2]Neuroprotection and cognitive support
Thymoquinone demonstrates neuroprotective effects in preclinical models of neurodegeneration (Alzheimer's, Parkinson's disease). Mechanisms include: antioxidant protection against neuronal oxidative stress, inhibition of acetylcholinesterase, suppression of neuroinflammation, and enhancement of neurotrophic factor expression. Thymohydroquinone also shows acetylcholinesterase inhibition. Clinical evidence for cognitive endpoints is limited but preclinical data are promising.
[2, 3]Urinary System
Nephroprotection (drug-induced kidney injury)
Preclinical studies demonstrate renal protection against gentamicin, cisplatin, methotrexate, and ischemia-reperfusion-induced nephrotoxicity. Thymoquinone enhances renal antioxidant defenses and reduces tubular necrosis. Limited clinical data, but the nephroprotective mechanism is well-characterized in animal models. Potential adjunctive use during nephrotoxic chemotherapy warrants investigation.
[1, 3]Kidney stones (nephrolithiasis)
Traditional Unani and Islamic medicine documents use of black seed for kidney stones and urinary complaints. Limited modern evidence. The diuretic action and possible effects on urinary calcium and oxalate excretion provide theoretical rationale. Ibn Sina described black seed for urinary conditions in the Canon of Medicine.
[1, 17]Lymphatic System
Lymphatic and immune system tonic
The immunomodulatory effects of N. sativa encompass the lymphatic system through enhancement of lymphocyte proliferation, NK cell activity, and macrophage function. Traditional Prophetic medicine emphasizes black seed as a comprehensive health protector affecting all body systems including lymphatic and immune function. The traditional dictum 'the remedy for everything except death' reflects the broad-spectrum tonic application.
[4, 16]Energetics
Temperature
warm
Moisture
slightly dry
Taste
Tissue States
cold/depression, damp/stagnation, damp/relaxation
In Unani (Greco-Arabic) medicine, Nigella sativa is classified as hot in the second degree and dry in the second degree (Har-2, Khushk-2), placing it firmly in the warm/drying category. The pronounced pungent and aromatic qualities indicate a dispersive, stimulating remedy that moves stagnation, warms cold conditions, and dries excessive dampness. In Ayurvedic interpretation, Kalonji is considered to reduce Kapha (cold/damp constitution) and Vata (cold/dry/erratic constitution) while potentially aggravating Pitta (hot/sharp constitution) in excess. The bitter component supports hepatobiliary function and metabolic processes. In Western herbal energetics, black seed is best suited for cold/depressed tissue states (weak immunity, sluggish metabolism, poor digestion with cold signs) and damp/stagnant states (congested liver, metabolic syndrome, respiratory congestion with thick mucus). The warming, drying energetics make it less appropriate for hot, dry, inflamed conditions without balancing formulation. CAVEAT: Herbal energetics are interpretive frameworks within traditional systems and are not standardized across all practitioners.
Traditional Uses
Islamic / Prophetic medicine (Tibb al-Nabawi)
- The most prominently featured medicinal seed in Prophetic medicine, recommended as a universal remedy
- Mixed with honey and consumed on an empty stomach as a general health tonic and immune protector
- Applied topically for headache (seed paste on forehead or temples)
- Inhaled (ground seed or oil) for nasal congestion, rhinitis, and sinusitis
- Taken internally for digestive complaints, stomach pain, intestinal worms, and diarrhea
- Used for respiratory conditions including cough, asthma, and chest tightness
- Applied externally for skin conditions, wounds, and joint pain
- Administered to nursing mothers to promote breast milk production
- Used as a remedy for toothache and oral infections
- Taken as a general fever remedy and for the common cold
"The Prophet Muhammad (peace be upon him) said: 'Use this black seed, for indeed it contains a cure for every disease except death.' (Sahih al-Bukhari, Book 71, Hadith 592). Ibn al-Qayyim al-Jawziyya in his Tibb al-Nabawi (Medicine of the Prophet, 14th century) provided extensive commentary: 'It is a remedy for all types of cold ailments... when it is ground, mixed with honey, and drunk with warm water, it dissolves kidney stones and bladder stones, and it is diuretic, produces menses, and increases the flow of breast milk.'"
Unani (Greco-Arabic) medicine
- Classified as hot (Har) and dry (Khushk) in the second degree
- Used as a muqawwi (general tonic) and mudirr-i-baul (diuretic)
- Prescribed for jaundice, hepatic congestion, and liver torpidity
- Applied for respiratory conditions: cough, asthma, and phlegmatic accumulation
- Used for worm infestation, abdominal distension, and digestive weakness
- Administered for rheumatic pain, paralysis, and facial palsy
- Applied topically as a poultice for boils, abscesses, and skin eruptions
- Used for dental caries and gum infections
- Prescribed for menstrual disorders and uterine complaints
- Combined with vinegar for head lice and skin parasites
"Ibn Sina (Avicenna) in Al-Qanun fi al-Tibb (The Canon of Medicine, ca. 1025 CE) describes Habbatus Sauda as having multiple therapeutic virtues: 'It stimulates the body's energy and helps recovery from fatigue and dispiritedness... It is beneficial against all kinds of cold ailments. Applied to the forehead, it relieves headache and nasal catarrh. When placed in a cloth and inhaled, it resolves colds. Its oil is beneficial for skin eruptions when applied locally.'"
Ayurvedic medicine (India)
- Known as Kalonji, Upakunchika, or Krishna Jiraka in Sanskrit texts
- Used for respiratory conditions: kasa (cough), shwasa (dyspnea/asthma), and pratishyaya (rhinitis/coryza)
- Prescribed for agnimandya (digestive weakness) and ajirna (indigestion)
- Applied for krimi (intestinal parasites) and udarashula (abdominal pain)
- Used in postpartum care to promote lactation and uterine recovery
- Applied externally for kushtha (skin diseases) and vrana (wounds)
- Used as a component of pancha deepagni churna (digestive fire-stimulating formulas)
- Classified as Kapha-Vata shamaka (reducing cold/damp and cold/erratic constitutions)
"In Ayurvedic texts including Charaka Samhita and Sushruta Samhita, Kalonji is described as having deepana (appetite-stimulating), pachana (digestive), and krimighna (antiparasitic) properties. The Bhavaprakash Nighantu classifies it as katu (pungent) and tikta (bitter) in rasa, ushna (hot) in virya, and katu in vipaka."
North African and Egyptian folk medicine
- Known as Habbat el-Baraka ('seed of blessing') in Egyptian Arabic
- Used as a general household remedy for headache, fever, and common colds
- Mixed with honey for cough, bronchitis, and sore throat
- Applied topically for eczema, boils, and fungal skin infections
- Used as an abortifacient and emmenagogue in folk practice (high doses)
- Seeds sprinkled on bread and pastries (traditional culinary use with perceived health benefits)
- Black seed oil rubbed on chest for respiratory congestion
- Used as a traditional remedy for scorpion and snake bites
- Applied for hair loss and premature graying
"Nigella sativa seeds have been found in the tomb of Tutankhamun (ca. 1323 BCE), indicating use in ancient Egyptian civilization over 3300 years ago. The Ebers Papyrus (ca. 1550 BCE), one of the oldest preserved medical texts, references a plant believed by some scholars to be Nigella sativa for digestive complaints and respiratory conditions, though definitive identification remains debated."
Traditional Middle Eastern and Turkish medicine
- Known as Corek otu in Turkish traditional medicine
- Used as a carminative and antiflatulent, mixed with food or brewed as tea
- Applied for diabetes management (seeds consumed daily)
- Used as a traditional remedy for hypertension and cardiovascular complaints
- Seeds mixed with yogurt for digestive health
- Black seed oil used as a general-purpose medicinal oil for internal and external complaints
- Applied as a remedy for chronic headaches and migraines
- Used for urinary tract infections and kidney complaints
"In Turkish folk medicine, Nigella sativa (Corek otu) has been used for centuries as a spice and medicine. Dioscorides (1st century CE) described Melanthion (believed to be Nigella sativa) in De Materia Medica: 'It is used for treating headache, nasal congestion, toothache, and intestinal worms. Mixed with vinegar, it is applied to skin eruptions.'"
Modern Research
Meta-analysis of metabolic effects of Nigella sativa supplementation
Systematic review and meta-analysis of randomized controlled trials evaluating the effects of N. sativa supplementation on metabolic parameters including fasting blood glucose, HbA1c, lipid profiles, body weight, and inflammatory markers.
Findings: N. sativa supplementation significantly reduced fasting blood glucose (WMD: -17.84 mg/dL, 95% CI: -21.19 to -14.49), HbA1c, total cholesterol, LDL-C, triglycerides, body weight, and BMI compared to placebo. Significant reductions in CRP and TNF-alpha confirmed anti-inflammatory effects. HDL-C showed a modest but significant increase. Effects were dose-dependent, with higher doses (2-3 g/day of seed or equivalent oil doses) showing greater metabolic improvement. The meta-analysis provided strong pooled evidence supporting N. sativa as an adjunctive intervention for metabolic syndrome and type 2 diabetes.
Limitations: Heterogeneity in N. sativa preparations (whole seed, seed oil, various extracts), dosing regimens, and treatment durations across included studies. Most studies were conducted in Middle Eastern and South Asian populations, limiting generalizability. Publication bias could not be fully excluded. Long-term follow-up data were lacking.
[6]
Meta-analysis of Nigella sativa effects on blood pressure and lipids
Systematic review and meta-analysis of RCTs examining the effects of N. sativa on blood pressure parameters and lipid profiles, providing the most comprehensive pooled evidence for cardiovascular risk factor modification.
Findings: N. sativa supplementation produced significant reductions in systolic blood pressure (WMD: -3.26 mmHg), diastolic blood pressure (WMD: -2.80 mmHg), total cholesterol (WMD: -15.65 mg/dL), LDL-C (WMD: -14.10 mg/dL), and triglycerides (WMD: -20.64 mg/dL). HDL-C increased significantly (WMD: +1.49 mg/dL). The powder form of N. sativa showed greater effects on lipid parameters than oil, possibly due to the additional fiber and protein content of whole seeds. Blood pressure reductions were clinically meaningful for population-level cardiovascular risk reduction.
Limitations: Moderate heterogeneity across studies. Variable N. sativa preparations and doses. Most studies 8-12 weeks duration; long-term cardiovascular outcome data are not available. Effect sizes, while statistically significant, are modest compared to pharmacological interventions. Potential publication bias.
[7]
Dose-dependent hypoglycemic effect of N. sativa in type 2 diabetes
Randomized, placebo-controlled clinical trial evaluating the effects of three doses of N. sativa seeds (1g, 2g, and 3g per day) on glycemic control in patients with type 2 diabetes mellitus over 12 weeks.
Findings: N. sativa at 2g/day produced the most significant reductions in fasting blood glucose (-56 mg/dL, P < 0.001 vs baseline) and HbA1c (-1.52%, P < 0.001) after 12 weeks. The 3g/day dose showed similar magnitude of effect. The 1g/day dose showed more modest improvements. Insulin resistance (HOMA-IR) improved significantly at 2g and 3g doses. Beta-cell function (HOMA-beta) also improved, suggesting partial restoration of pancreatic function. No significant hypoglycemic episodes were reported. Lipid profiles showed concurrent improvements at higher doses.
Limitations: Single-center study conducted in Saudi Arabia. Relatively small sample size per dose group. 12-week duration may not capture long-term glycemic trajectory. Patients continued metformin therapy; the results reflect adjunctive use. The preparation was whole crushed seeds in capsules; results may differ with other preparations.
[5]
Comprehensive review of pharmacological activities of Nigella sativa
Extensive narrative review of the pharmacological and therapeutic properties of N. sativa, covering over 200 studies across multiple therapeutic areas including anti-inflammatory, antidiabetic, anticancer, analgesic, antimicrobial, hepatoprotective, renal protective, gastroprotective, and immunomodulatory activities.
Findings: Documented thymoquinone as the principal bioactive constituent responsible for the majority of pharmacological effects. Confirmed anti-inflammatory effects through NF-kB suppression, COX-2 inhibition, and cytokine modulation. Reviewed evidence for hepatoprotection against multiple toxicants. Summarized anticancer effects including apoptosis induction, cell cycle arrest, and anti-angiogenesis across multiple cancer cell lines. Documented immunomodulatory effects on both innate and adaptive immunity. Confirmed hypoglycemic, hypolipidemic, and antihypertensive effects. Overall assessment characterized N. sativa as one of the most extensively studied medicinal plants with a remarkably broad pharmacological profile.
Limitations: Narrative review without formal systematic methodology or meta-analytic pooling. Many cited studies were preclinical (in vitro, in vivo) with uncertain clinical translation. Variable quality of cited clinical studies. The breadth of claimed activities requires careful critical evaluation of evidence strength for each specific indication.
[1]
Review of thymoquinone pharmacology and toxicology
Comprehensive review of the pharmacological effects and safety profile of thymoquinone, the primary active compound of N. sativa, covering mechanisms of action, therapeutic applications, pharmacokinetics, and toxicity.
Findings: Detailed the mechanisms underlying thymoquinone's anti-inflammatory (NF-kB, COX-2, 5-LOX inhibition), antioxidant (direct radical scavenging, GSH enhancement, SOD/CAT induction), anticancer (apoptosis, cell cycle arrest, anti-angiogenesis), and organ-protective activities. Identified key pharmacokinetic limitations: poor oral bioavailability due to first-pass metabolism, lipophilicity requiring oil-based delivery, and dose-dependent absorption. Reviewed toxicity data: oral LD50 in mice and rats ranged from 870-2400 mg/kg depending on species and route, indicating a wide therapeutic margin. Chronic toxicity studies at therapeutic doses showed no significant organ damage. Confirmed hepatoprotective and nephroprotective effects across multiple toxicant models.
Limitations: The majority of mechanistic data are from in vitro and animal studies. Pharmacokinetic data in humans are limited. Bioavailability enhancement strategies (nanoformulations, liposomal encapsulation) are under investigation but not yet clinically standardized. Dose equivalence between animal and human studies requires careful allometric scaling.
[3]
Immunomodulatory effects of Nigella sativa: comprehensive review
Comprehensive review of the immunomodulatory properties of N. sativa and its active constituents, covering effects on both innate and adaptive immune function in preclinical and clinical studies.
Findings: N. sativa and thymoquinone enhance multiple arms of the immune system: increased NK cell cytotoxicity, enhanced macrophage phagocytic activity, stimulation of lymphocyte proliferation, modulation of Th1/Th2 cytokine balance, and augmentation of antibody-dependent cellular cytotoxicity. In immunocompromised models, N. sativa restored immune function toward normal. In allergic/autoimmune models, it modulated excessive immune activation, demonstrating bidirectional immunomodulation. Clinical studies confirmed enhanced T-cell subsets (CD4+, CD8+) and NK cell activity in healthy volunteers and in patients with immune-related conditions. The immunomodulatory profile supports the traditional use of black seed as a comprehensive immune tonic.
Limitations: Many studies used different preparations and dosing, making direct comparison difficult. The concept of 'bidirectional immunomodulation' requires more rigorous clinical validation. Long-term immunological effects in humans are not well characterized. Interaction with immunosuppressive medications is a theoretical concern requiring further study.
[4]
Nigella sativa in asthma: systematic review of clinical evidence
Systematic review of clinical studies evaluating the efficacy of N. sativa in the treatment of asthma, including effects on pulmonary function, symptom scores, and inflammatory biomarkers.
Findings: N. sativa supplementation was associated with significant improvement in asthma symptoms and pulmonary function parameters (FEV1, PEFR) across the reviewed studies. Anti-asthmatic mechanisms included bronchodilation through calcium channel blockade, antihistaminic effects (nigellone), anti-inflammatory activity (thymoquinone), and immunomodulation (Th1/Th2 rebalancing). The oil form and boiled seed extract showed the most consistent benefits. Improvements were observed as adjunctive therapy alongside conventional asthma medications.
Limitations: Limited number of high-quality RCTs available. Most studies were small and conducted in Middle Eastern populations. Heterogeneity in preparations and dosing. Short study durations (typically 4-12 weeks). Asthma severity classification varied across studies.
[10]
Bronchodilatory effects of N. sativa in asthmatic patients
Clinical trial comparing the bronchodilatory effects of boiled N. sativa seed extract with theophylline in asthmatic patients, measuring pulmonary function parameters.
Findings: Boiled extract of N. sativa (50 mg/kg/day) significantly improved all measured pulmonary function parameters (FEV1, PEFR, FEF25-75%) in asthmatic patients compared to placebo. The bronchodilatory effect was less potent than theophylline but reached statistical significance. The effect was most pronounced in subjects with moderate asthma. No significant adverse effects were reported. The results confirmed the traditional use of black seed for respiratory conditions and provided clinical evidence for the bronchodilatory mechanism.
Limitations: Single-center study with small sample size. Boiled extract preparation is not the most common commercial form available. Short-term assessment; duration of effect with chronic use not established. Comparison with theophylline (an older medication) rather than current first-line asthma treatments.
[8]
N. sativa oil for allergic rhinitis
Randomized, double-blind, placebo-controlled clinical trial evaluating intranasal application of N. sativa oil for the treatment of allergic rhinitis symptoms.
Findings: Intranasal application of N. sativa oil for 2 weeks significantly reduced nasal mucosal congestion (P < 0.001), nasal itching (P < 0.002), rhinorrhea (P < 0.015), sneezing attacks (P < 0.002), turbinate hypertrophy (P < 0.001), and mucosal pallor (P < 0.001) compared to placebo. Total symptom scores were significantly improved. The results were consistent with the antihistaminic, anti-inflammatory, and immunomodulatory properties of thymoquinone and other N. sativa constituents acting locally on the nasal mucosa.
Limitations: Relatively small sample size (66 patients). Short treatment duration (2 weeks). Single-center study. Long-term outcomes and optimal dosing frequency not established. Intranasal application route; results may not directly generalize to oral supplementation for allergic rhinitis.
[9]
N. sativa supplementation in rheumatoid arthritis
Randomized, double-blind, placebo-controlled trial evaluating the effects of N. sativa oil supplementation on disease activity, inflammatory markers, and oxidative stress in female patients with rheumatoid arthritis.
Findings: N. sativa oil (500 mg capsules twice daily for 8 weeks) significantly reduced Disease Activity Score-28 (DAS-28) compared to placebo (P < 0.05). Number of swollen joints, tender joints, and morning stiffness duration decreased significantly. Serum TNF-alpha and IL-10 showed favorable modulation. Oxidative stress markers improved. The results support the use of N. sativa oil as an adjunctive anti-inflammatory intervention in rheumatoid arthritis.
Limitations: Female-only study population. Small sample size. 8-week duration; long-term efficacy not established. Patients continued conventional DMARD therapy; results reflect adjunctive use only. Single-center study.
[11]
N. sativa oil effects on male infertility parameters
Randomized clinical trial evaluating the effects of daily N. sativa oil supplementation on semen parameters in infertile men.
Findings: Supplementation with 2.5 mL/day of N. sativa oil for 2 months resulted in significant improvements in sperm count, sperm motility, sperm morphology, and semen volume compared to baseline and control group. The improvements were attributed to the antioxidant properties of thymoquinone protecting sperm from oxidative damage, as well as potential effects on testosterone synthesis and Leydig cell function. Semen malondialdehyde (MDA, an oxidative stress marker) decreased significantly.
Limitations: Relatively small sample size. 2-month treatment duration; fertility outcomes (pregnancy rates) not reported. The specific cause of infertility was not subclassified. A single preparation and dose was tested. Further larger trials with clinical pregnancy endpoints are needed.
[12]
N. sativa in Hashimoto's thyroiditis
Randomized, double-blind, placebo-controlled trial evaluating the effects of N. sativa supplementation on thyroid function, anthropometric variables, and vascular endothelial growth factor (VEGF) in patients with Hashimoto's thyroiditis.
Findings: N. sativa supplementation (2g powdered seed/day for 8 weeks) significantly reduced body weight, BMI, waist circumference, serum TSH, anti-thyroid peroxidase (anti-TPO) antibody levels, and serum VEGF. Serum T3 concentration increased significantly while T4 remained stable. The reduction in anti-TPO antibodies suggested modulation of the autoimmune process. The results indicate potential thyroid function-supportive and immunomodulatory effects in autoimmune thyroid disease.
Limitations: Small sample size (40 patients). Short treatment duration (8 weeks). Single-center study in an Iranian population. Long-term effects on thyroid autoimmunity progression not established. Replication needed before clinical recommendations.
[13]
Comprehensive review of biological and pharmacological activities of N. sativa
Extensive review of the multi-target pharmacological profile of N. sativa covering analgesic, anti-inflammatory, antimicrobial, anticancer, cardiovascular, gastroprotective, hepatoprotective, nephroprotective, neuroprotective, and pulmonary protective activities with emphasis on molecular mechanisms.
Findings: Documented the remarkable breadth of pharmacological activities, with thymoquinone identified as the principal effector molecule in the majority of systems. Key mechanisms were consistently identified across studies: NF-kB pathway inhibition (anti-inflammatory, anticancer), oxidative stress mitigation (organ-protective effects), and immune cell modulation (immunomodulatory effects). The review emphasized the multi-target nature of thymoquinone as both an advantage (addressing complex, multi-pathway diseases) and a challenge (difficulty in attributing effects to single mechanisms). The overall safety profile was favorable, with no serious toxicity at recommended doses.
Limitations: Narrative review format. Many referenced studies were preclinical. The enormous breadth of claimed activities sometimes exceeds the clinical evidence base. Risk of selection bias in study citation. Need for more rigorous, well-powered clinical trials for specific indications.
[2]
N. sativa anti-Helicobacter pylori activity
Clinical study comparing the anti-Helicobacter pylori activity of N. sativa seeds with standard triple therapy in patients with confirmed H. pylori infection.
Findings: N. sativa seeds (2g/day) combined with omeprazole achieved H. pylori eradication rates comparable to triple therapy (containing clarithromycin and amoxicillin) in the study population. The result was attributed to the direct antibacterial activity of thymoquinone and other volatile constituents against H. pylori, combined with the gastroprotective and acid-reducing effects. The combination of N. sativa with a proton pump inhibitor showed promise as a potential alternative to antibiotic-based triple therapy, particularly relevant in areas of high antibiotic resistance.
Limitations: Small sample size. Single-center study. H. pylori eradication was confirmed by urea breath test without endoscopic verification. Comparison with current standard quadruple therapy (rather than older triple therapy) would be more clinically relevant. Resistance patterns of the local H. pylori strains were not characterized. Replication in larger, multi-center trials is essential before adoption.
[14]
Preparations & Dosage
Capsule / Powder
Strength: Ground seed powder: 400-500 mg per capsule. Standardized extract: varies by manufacturer, typically standardized to 1-5% thymoquinone.
Whole black seeds are dried, finely ground to a powder, and encapsulated. Alternatively, standardized seed extract powder (concentrated) is encapsulated. Ensure seeds are fresh, aromatic, and free from mold. Standard capsules contain 400-500 mg of ground seed. Capsules should be taken with food and water to improve absorption and reduce potential gastric irritation.
1-3 g ground seed powder per day (2-6 capsules of 500 mg), taken in divided doses. Most clinical trials used 2 g/day for metabolic indications.
Two to three times daily with meals
Clinical trials typically used 8-12 weeks of continuous supplementation. May be used long-term as a daily supplement based on extensive traditional use. Reassess therapeutic need periodically.
Not well-established for children under 12. Small amounts of seeds used in food (culinary doses) have a long tradition of safety. Therapeutic doses: adolescents over 12 may use half adult dose under practitioner guidance.
Ground seed capsules are the most commonly studied form in clinical trials for metabolic indications (Bamosa et al. 2010 used crushed seeds in capsules at 1-3 g/day). Ground seed powder provides the full phytochemical matrix including fixed oils, volatile oils, protein, and fiber. Standardized extracts concentrated for thymoquinone may offer more potent effects per weight but may lack some synergistic matrix compounds. Product quality is variable; choose products that specify N. sativa species, thymoquinone content, and have third-party testing.
Standardized Extract
Strength: Cold-pressed seed oil: thymoquinone content typically 0.5-3.0% by weight (varies with seed source and processing). Supercritical CO2 extract: may contain up to 5% thymoquinone. Soft-gel capsules: typically 500 mg or 1000 mg per capsule.
Commercially prepared black seed oil in soft-gel capsules, cold-pressed or supercritical CO2 extracted, standardized to minimum thymoquinone content (typically 1-3% for cold-pressed oil, up to 5% for concentrated extracts). Take with food to enhance absorption of lipophilic constituents. Store in refrigerator or cool, dark location to prevent oxidative degradation of thymoquinone and polyunsaturated fatty acids.
1-3 mL (approximately 1-3 g) of cold-pressed seed oil per day, or 500-1000 mg seed oil soft-gel capsules 2-3 times daily. Higher thymoquinone-standardized extracts: follow manufacturer dosing based on thymoquinone content.
Two to three times daily, with meals
Clinical trials used 4-12 weeks. Long-term use appears safe based on traditional practice. Monitor relevant clinical parameters.
Not established for standardized oil extracts in children
Black seed oil is the most popular contemporary preparation and the form most readily available commercially. Cold-pressing preserves the thymoquinone content and fatty acid profile better than solvent extraction or high-heat processing. The oil serves as its own delivery vehicle for the lipophilic active constituents. Quality markers include: dark amber color, strong pungent aroma, and a warm, slightly burning aftertaste. The oil should not taste rancid or excessively mild (indicating poor quality or dilution). Some manufacturers provide thymoquinone assay values on the label. Store refrigerated after opening.
Infusion (Tea)
Strength: 3-5 g crushed seeds per 250 mL water; infusion ratio approximately 1:50-1:80
Crush or lightly grind 1-2 teaspoons (3-5 g) of whole black seeds using a mortar and pestle to release aromatic oils. Add to a cup (250 mL) of just-boiled water. Cover tightly and steep for 10-15 minutes (covering is important to retain volatile oils). Strain and drink. Can be sweetened with honey. Some traditional preparations involve briefly toasting the seeds in a dry pan before crushing and steeping, which modifies the flavor profile.
1-2 cups daily, prepared with 3-5 g of seeds per cup
One to two times daily, ideally on an empty stomach or between meals
May be used daily as a tonic tea. Consistent with traditional culinary-medicinal use.
Half-strength preparation for children over 6 under practitioner guidance. Culinary use in food is traditional.
Infusion (tea) is a simple traditional preparation accessible for daily use. It extracts water-soluble constituents including some alkaloids, saponins, and proteins, along with a portion of the volatile oils (retained by covering during steeping). However, the lipophilic thymoquinone and fixed oil fatty acids are not efficiently extracted by hot water alone, so this preparation is less therapeutically potent for indications requiring maximal thymoquinone delivery (metabolic, hepatoprotective effects). Best suited for mild digestive, respiratory, and general tonic applications. In Islamic tradition, the seeds are often simply chewed and swallowed rather than prepared as a tea.
Tincture
Strength: 1:5, 50-60% ethanol (dried seed). Fresh seed: 1:3 in 65% ethanol.
Finely grind dried black seeds. Macerate at a ratio of 1:5 in 50-60% ethanol for 4-6 weeks with daily agitation. Press, filter, and bottle in amber glass. The moderately high alcohol percentage is needed to extract both the volatile terpene constituents and the fixed oil-associated thymoquinone. Alternatively, a spagyric or dual-extraction approach (ethanol extraction + separate aqueous extraction) can capture a broader phytochemical spectrum.
2-4 mL (40-80 drops) three times daily
Two to three times daily
May be used for extended periods. Reassess periodically.
Not recommended due to alcohol content. Use glycerite or seed preparation instead.
Tincture is less commonly used for N. sativa than oil or capsule preparations, but provides an alternative liquid delivery form compatible with herbal formula blending. The hydroalcoholic extraction captures volatile oils, alkaloids, saponins, and some of the fixed oil-associated thymoquinone. However, it does not deliver the full fatty acid profile that oil preparations provide. Best suited for practitioners who wish to include N. sativa in custom tincture formulations for respiratory, digestive, or immune-supporting blends.
[1]
Essential Oil
Strength: Pure essential oil: thymoquinone content 27-57% (highly concentrated). Dilute appropriately before any use.
Steam-distilled essential oil of N. sativa seeds. For topical use: dilute to 1-5% in a carrier oil (e.g., olive oil, coconut oil, or the plant's own cold-pressed fixed oil). For aromatic use: diffuse or inhale directly from the bottle for respiratory conditions. For internal use (advanced practice only): 1-2 drops in a capsule or mixed with honey, under practitioner guidance. The essential oil is significantly more concentrated in thymoquinone than the cold-pressed fixed oil and must be used with appropriate dilution.
Topical: 1-5% dilution in carrier oil, applied to affected area 2-3 times daily. Internal: 1-2 drops (approximately 50-100 mg) in a capsule with carrier oil, 1-2 times daily under practitioner guidance.
Topical: 2-3 times daily. Internal: 1-2 times daily.
Topical: as needed. Internal: short courses (2-4 weeks) with reassessment.
Not recommended for internal use in children. Topical use at 1% dilution in appropriate carrier oil for children over 6.
The essential oil is the most concentrated source of thymoquinone and related volatile constituents but requires careful handling and appropriate dilution. It is distinct from the cold-pressed fixed oil (black seed oil) which is much milder and contains the full fatty acid matrix. Do not confuse the two; the essential oil is too potent for direct application or internal use without dilution. Topical application is useful for skin conditions, joint pain, and localized infections. Inhalation is appropriate for nasal and respiratory complaints (consistent with traditional use described by Ibn Sina). Internal use of essential oil should only be undertaken with professional guidance.
Poultice
Strength: Ground seed paste: approximately 1 part ground seed to 1-2 parts honey or oil
Grind black seeds to a coarse or fine powder. Mix with warm water, honey, or olive oil to form a paste. Apply directly to the affected area and cover with a clean cloth or gauze. Leave in place for 30-60 minutes. For joint pain: apply warm poultice to affected joint, wrap with warm cloth. For headache: apply paste to temples and forehead. For skin conditions: apply to affected skin area. Refresh poultice 1-2 times daily.
1-2 tablespoons of ground seed mixed with sufficient honey or oil to form a paste. Applied externally as needed.
1-2 times daily as needed
Continue until condition improves. Discontinue if skin irritation develops.
Suitable for external use in children over 2 years with appropriate supervision.
Poultice application is a traditional method described in Prophetic medicine and Unani practice for headache, joint pain, skin infections, and inflammatory skin conditions. The topical route provides direct delivery of thymoquinone and other antimicrobial/anti-inflammatory constituents to the affected area. The pungent volatile oils may cause a mild warming sensation on application, which is normal and consistent with the herb's warm energetics. Discontinue if significant irritation or allergic reaction occurs. Patch test on a small area before widespread application in sensitive individuals.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Although rare, allergic reactions to N. sativa have been reported, including contact dermatitis from topical application and isolated cases of anaphylaxis. Individuals with known allergy to N. sativa, other Nigella species, or members of the Ranunculaceae (buttercup) family should avoid use.
Therapeutic doses (> 1-2 g/day of seed or equivalent oil) are considered possibly unsafe during pregnancy. N. sativa has demonstrated uterotonic (smooth muscle contracting) effects in animal studies, and traditional use in some cultures has included high-dose N. sativa as an emmenagogue and abortifacient. Culinary amounts of black seed used as a spice in food have a long history of safe use during pregnancy and are not contraindicated. The distinction between culinary and therapeutic doses is critical.
N. sativa may potentiate bleeding risk due to mild antiplatelet and anticoagulant effects and may potentiate anesthetic agents due to sedative/analgesic properties. As a precautionary measure, therapeutic doses should be discontinued 1-2 weeks before elective surgical procedures.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Metformin, sulfonylureas, insulin, and other antidiabetic medications (Hypoglycemic agents) | moderate | Additive blood glucose-lowering effects. N. sativa demonstrates significant hypoglycemic activity through improvement of insulin sensitivity, enhancement of beta-cell function, and increased hepatic glucose utilization. Combined with pharmacological hypoglycemics, clinically significant additive effects may occur. |
| Warfarin, heparin, and other anticoagulants (Anticoagulants) | moderate | Potential additive anticoagulant/antiplatelet effects. N. sativa has demonstrated inhibition of platelet aggregation and thromboxane B2 production in vitro and in animal models. Thymoquinone may also affect coagulation cascade factors. |
| Antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers, diuretics, beta-blockers) (Antihypertensives) | minor | Additive blood pressure-lowering effect through multiple mechanisms: calcium channel blockade, diuretic action, and nitric oxide-mediated vasodilation. |
| Cyclosporine, tacrolimus, and other immunosuppressants (Immunosuppressants) | theoretical | N. sativa's immunomodulating (immune-enhancing) properties could theoretically oppose the effects of immunosuppressive medications. Enhancement of T-cell, NK cell, and macrophage activity could counteract drug-induced immunosuppression. |
| CYP450 substrate drugs (general) (Cytochrome P450 substrates) | theoretical | In vitro studies suggest thymoquinone may inhibit certain CYP450 enzymes (CYP1A2, CYP3A4), potentially affecting the metabolism of drugs processed by these enzymes. The clinical relevance at typical dietary supplement doses is uncertain. |
| Phenytoin, carbamazepine, valproic acid, and other anticonvulsant medications (Anticonvulsants) | theoretical | N. sativa and thymoquinone demonstrate anticonvulsant activity through GABAergic modulation and possibly opioid receptor interaction. Combined use with pharmaceutical anticonvulsants could theoretically produce additive effects, potentially altering seizure threshold or drug metabolism. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
PREGNANCY: Therapeutic doses of N. sativa are classified as possibly unsafe during pregnancy based on: (1) demonstrated uterotonic effects (smooth muscle contraction) in animal studies, (2) traditional use as an emmenagogue and abortifacient at high doses in some folk medicine traditions, and (3) absence of controlled safety studies in pregnant women. Culinary amounts (a few seeds as a spice in food) have a long history of traditional use during pregnancy and are generally considered safe, reflecting the dose-dependent nature of the concern. The critical distinction is between culinary (< 1g/day as food flavoring) and therapeutic (1-3 g/day as medicine) doses. LACTATION: N. sativa is traditionally used as a galactagogue (breast milk promoter) in Islamic and Unani medicine, and traditional practice supports its use during lactation. However, there are no controlled clinical studies establishing safety during breastfeeding. Thymoquinone's transfer into breast milk has not been characterized. Culinary use during lactation is likely safe based on traditional practice, but therapeutic doses should be used with caution under practitioner guidance.
Adverse Effects
References
Monograph Sources
- [1] Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed (2013) ; 3 : 337-352 . DOI: 10.1016/S2221-1691(13)60075-1 . PMID: 23646296
- [2] Forouzanfar F, Bazzaz BSF, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci (2014) ; 17 : 929-938 . PMID: 25859296
- [3] Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J Pharmacopuncture (2017) ; 20 : 179-193 . DOI: 10.3831/KPI.2017.20.021 . PMID: 30087795
- [4] Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol (2005) ; 5 : 1749-1770 . DOI: 10.1016/j.intimp.2005.06.008 . PMID: 16275613
Clinical Studies
- [5] Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol (2010) ; 54 : 344-354 . PMID: 21675032
- [6] Daryabeygi-Khotbehsara R, Golzarand M, Ghaffari MP, Djafarian K. Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis. Complement Ther Med (2017) ; 35 : 6-13 . DOI: 10.1016/j.ctim.2017.08.016 . PMID: 29154054
- [7] Sahebkar A, Beccuti G, Simental-Mendia LE, Nobili V, Bo S. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacol Res (2016) ; 106 : 37-50 . DOI: 10.1016/j.phrs.2016.02.008 . PMID: 26875640
- [8] Boskabady MH, Mohsenpoor N, Takaloo L. Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine (2010) ; 17 : 707-713 . DOI: 10.1016/j.phymed.2010.01.002 . PMID: 20149611
- [9] Nikakhlagh S, Rahim F, Aryani FH, Syahpoush A, Brougerdnya MG, Saki N. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol (2011) ; 32 : 402-407 . DOI: 10.1016/j.amjoto.2010.07.019 . PMID: 20947211
- [10] Koshak A, Wei L, Koshak E, Wali S, Alamoudi O, Demerdash A, Qutub M, Pushparaj PN, Heinrich M. Nigella sativa supplementation improves asthma control and biomarkers: A randomized, double-blind, placebo-controlled trial. Phytother Res (2017) ; 31 : 403-409 . DOI: 10.1002/ptr.5761 . PMID: 28093815
- [11] Hadi S, Mirmiran P, Daryabeygi-Khotbehsara R, Hadi V. Effect of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Avicenna J Phytomed (2016) ; 6 : 34-43 . PMID: 27247920
- [12] Kolahdooz M, Nasri S, Modarres SZ, Kianbakht S, Huseini HF. Effects of Nigella sativa L. seed oil on abnormal semen quality in infertile men: a randomized, double-blind, placebo-controlled clinical trial. Phytomedicine (2014) ; 21 : 901-905 . DOI: 10.1016/j.phymed.2014.02.006 . PMID: 24680621
- [13] Farhangi MA, Dehghan P, Tajmiri S, Abbasi MM. The effects of Nigella sativa on thyroid function, serum vascular endothelial growth factor (VEGF)–1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial. BMC Complement Altern Med (2016) ; 16 : 471 . DOI: 10.1186/s12906-016-1432-2 . PMID: 27852303
- [14] Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, Randhawa MA. Comparative study of Nigella sativa and triple therapy in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol (2010) ; 16 : 207-214 . DOI: 10.4103/1319-3767.65201 . PMID: 20616418
Traditional Texts
- [15] Imam Muhammad ibn Ismail al-Bukhari. Sahih al-Bukhari, Book 71 (Medicine), Hadith 592. Compiled ca. 846 CE; multiple translations and editions available (846)
- [16] Ibn Qayyim al-Jawziyya. Al-Tibb al-Nabawi (Medicine of the Prophet). Written ca. 1330 CE; translated by Penelope Johnstone, The Islamic Texts Society, Cambridge, 1998 (1330)
- [17] Ibn Sina (Avicenna). Al-Qanun fi al-Tibb (The Canon of Medicine), Book II. Written ca. 1025 CE; multiple translations available (1025)
- [18] Bhavamishra. Bhavaprakash Nighantu (Indian Materia Medica). Written ca. 16th century CE; commentary by K.C. Chunekar (1550)
Pharmacopeias & Reviews
- [19] Government of India, Ministry of AYUSH. The Ayurvedic Pharmacopoeia of India, Part I, Volume IV: Upakunchika (Nigella sativa). The Controller of Publications, Civil Lines, Delhi (2004)
- [20] Government of India, Ministry of AYUSH. National Formulary of Unani Medicine, Part I: Kalonji (Nigella sativa). Central Council for Research in Unani Medicine (2006)
- [21] Ministry of Health, Arab Republic of Egypt. Egyptian Pharmacopoeia: Nigella sativa seed monograph. National Organization for Drug Control and Research, Cairo (2005)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.